PROGENIKA BIOPHARMA S.L.
- Shared products
- ANTI-ADALIMUMAB ANTIBODIES (ADL), ANTI-INFLIXIMAB (IFX) ANTIBODIES, INFLIXIMAB (IFX)
- Shared products
- ANTI-ADALIMUMAB ANTIBODIES (ADL), ANTI-INFLIXIMAB (IFX) ANTIBODIES, INFLIXIMAB (IFX)
- Shared products
- IMMUNOHEMATOLOGY - RH-HR, KELL, KIDD, DUFFY - MONOCLONAL ORIGIN, Software
- Shared products
- HUMAN PLATELET ANTIGENS (HPA), Software
- Shared products
- ANTI-INFLIXIMAB (IFX) ANTIBODIES, INFLIXIMAB (IFX)
Explore comprehensive manufacturer profile for PROGENIKA BIOPHARMA S.L. based in Spain through Pure Global AI's free Brazil medical device database. This manufacturer has 10 products registered with ANVISA across 6 unique technical categories. Their regulatory history spans from Jan 18, 2016 to Jun 30, 2025.
This page provides detailed insights including 5 recent product registrations including IMMUNOHEMATOLOGY - RH-HR, KELL, KIDD, DUFFY - MONOCLONAL ORIGIN, 5 most popular products with IMMUNOHEMATOLOGY - RH-HR, KELL, KIDD, DUFFY - MONOCLONAL ORIGIN having 3 registrations, 1 registration holders including GRIFOLS BRASIL LTDA, and 5 key competitors with BODITECH MED INC. sharing 3 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.